Exhibit 10.1 GENES TO LEADS(R) AGREEMENT CENGENT'S LEAD IDENTIFICATION PROGRAM IN DRUG DISCOVERY BASIC TERMS The basic terms of this Genes-to-Leads(R) Agreement ("AGREEMENT") are: 1. Effective Date of Agreement: June 7, 2004. 2. Parties (collectively...AngioGenex, Inc. • January 9th, 2006 • Communications services, nec • California
Exhibit 10.2 GENES TO LEADS(R) AGREEMENT CENGENT'S LEAD IDENTIFICATION PROGRAM IN DRUG DISCOVERY BASIC TERMS The basic terms of this Genes-to-Leads(R) Agreement ("AGREEMENT") are: 1. Effective Date of Agreement: June 6, 2004. 2. Parties (collectively...AngioGenex, Inc. • January 9th, 2006 • Communications services, nec • California
EXHIBIT 10(b) EMPLOYMENT AGREEMENT BY AND BETWEEN THE COMPANY AND SKYELAN ROSE DATED MARCH 1, 1998 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (the "Agreement"), effective as of the 1st day of March 1999, by and between eClic, INC., a Nevada...Employment Agreement • May 24th, 1999 • Eclic Inc/Nv • Arizona
Exhibit 10.5 LEGAL/ADMINISTRATIVE OPTION AGREEMENT WITH THE LAW OFFICES OF THOMAS C. COOK, LTD This Legal/Administrative option agreement ("Agreement") is made as of this 31st day of January, 2007, by and between The Law Offices of Thomas C. Cook,...Option Agreement • May 25th, 2007 • AngioGenex, Inc. • Communications services, nec • Nevada
RECITALSSubscription Agreement • September 1st, 2006 • AngioGenex, Inc. • Communications services, nec • Nevada
EXCLUSIVE LICENSE AGREEMENT --------------------------- (SK#4771)Exclusive License Agreement • January 9th, 2006 • AngioGenex, Inc. • Communications services, nec • New York
EXHIBIT 10(a) EMPLOYMENT AGREEMENT BY AND BETWEEN THE COMPANY AND J. M. DANIELS DATED MARCH 1, 1998 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (the "Agreement"), effective as of the 1st day of March 1999, by and between eClic, INC., a Nevada...Employment Agreement • May 24th, 1999 • Eclic Inc/Nv • Arizona
EXCLUSIVE LICENSE AGREEMENT for MSK's technology “Novel Compounds for Inhibition of Id”Exclusive License Agreement • February 11th, 2020 • AngioGenex, Inc. • Pharmaceutical preparations • New York
RESEARCH STUDY AGREEMENT This Agreement (the "Agreement") is dated as of September 24, 2001, by and between AngioGenex, Inc., a New York corporation having an office at 825 3rd Avenue, New York, New York 10021 (the "Company"), and Biocheck (the...Research Study Agreement • January 9th, 2006 • AngioGenex, Inc. • Communications services, nec • California
MODIFICATION TO DEVELOPMENT AND MARKETING AGREEMENTModification to Development and Marketing Agreement • July 25th, 2008 • AngioGenex, Inc. • Communications services, nec
THIS MODIFICATIONAGREEMENT dated July 21, 2008 applies to the DEVELOPMENT AND MARKETING AGREEMENT (the "Agreement') made and entered into and effective as of December 15, 2003 by and between BioCheck, Inc., a California corporation ('BioCheck") and AngioGenex, Inc., a New York corporation ("Angio').
AMONGAgreement and Plan of Reorganization • December 30th, 2005 • Eclic Inc/Nv • Communications services, nec • Nevada
